More Clinical Articles

Clinical

Clinical Pathways in Oncology

Danielle Barron, (May 1, 2015)

Danielle Barron reports on the increasing popularity of evidence-based clinical pathways & the implications for manufacturers.
Clinical

Payer-Reform for Physicians — Moving from Volume-Based to Value-Based Reimbursement

Suzanne Shelley, (Apr 27, 2015)

Dr Edward J. Benz, CEO of Dana Farber Cancer Institute discusses physician payment reform and its practical implications.
Clinical

The Future of Clinical Trials

George Winter, (Apr 16, 2015)

Patient-centric trials offer huge opportunity but what are the barriers to implementation?
Clinical

Successful Pharmacovigilance: Harnessing Relationships between Stakeholders

Dr Nicola Davies, (Apr 16, 2015)

What makes pharmacovigilance effective and efficient is the trust between the different parties and stakeholders.
Clinical

4 Ways to Guarantee your Trials Become More Patient-Centric

Zuzanna Fimińska, (Apr 16, 2015)

Could trials be at risk of being invalidated by rebellion from patients?
Clinical

Risk Sharing Agreements on the American Horizon

Danielle Barron, (Apr 16, 2015)

US stakeholders are beginning to consider risk sharing agreements, but to what effect?
Clinical

Alzheimer’s: Can we save the world from a public health disaster?

Zuzanna Fimińska, (Apr 2, 2015)

Alzheimer’s disease is a ticking time bomb for public health around the world. If we don’t act now, it will single-handedly devastate global healthcare systems.
Clinical

Partnership: The Game Changer in Alzheimer’s Research

Danielle Barron, (Apr 1, 2015)

A unique public-private partnership aims to change the face of Alzheimer’s dementia research by avoiding the duplication of research efforts. Danielle Barron speaks to those involved to find out why this new approach may finally lead to effective treatments for the condition.
Clinical

Patient Centered Clinical Trials

Dr Nicola Davies, (Mar 30, 2015)

As pharmaceutical companies compete to bring new drugs to market, there is an increasing emphasis on the need for patient centricity – to retain patient volunteers and produce quality data. We spoke to Duncan Cantor, Director of Communications, Boehringer Ingelheim, about the importance of patient centricity in clinical trials.
Clinical

Time to flourish

Adam Hill, (Mar 22, 2015)

Failure is going to be part of the process with biosimilars, but for companies with an entrepreneurial spirit and a clear mindset, the rewards are also there...

Pages